Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Targeted Physical Activity to Improve Mobility and Falls Risk in Women Living With Ovarian Cancer
- Status
- UNKNOWN
- Phase
- NA
A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet
- Status
- COMPLETED
- Phase
- NA
Visualisation of Indocyanine Green in Primary and Interval Debulking for Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE2
D9319C00001- 1L OC Mono Global RCT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Intra-operative Imaging in Women With Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures
- Status
- TERMINATED
- Phase
- PHASE3
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
- Status
- RECRUITING
- Phase
- PHASE1
Non-interventional Study to Collect Real-world Clinical and Patient-reported Outcomes in Ovarian Cancer
- Status
- RECRUITING
- Phase
- N/A
Study of DP303c Injection in Patients With Advanced Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Efficacy of AsiDNATM, a DNA Repair Inhibitor, Administered Intravenously in Addition to PARP Inhibitors in Patients With Relapsed Platinum Sensitive Ovarian Cancer Already Treated With PARP Inhibitors Since at Least 6 Months
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Early Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex Sequencing
- Status
- COMPLETED
- Phase
- NA
4FMFES-PET Imaging of Endometrial and Ovarian Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System
- Status
- COMPLETED
- Phase
- N/A